Logo image of CSPN.CA

CARESPAN HEALTH INC (CSPN.CA) Stock Fundamental Analysis

TSX-V:CSPN - TSX Venture Exchange - CA14174J1093 - Common Stock - Currency: CAD

0.02  +0.01 (+33.33%)

Fundamental Rating

0

CSPN gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. Both the profitability and financial health of CSPN have multiple concerns. CSPN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

CSPN had negative earnings in the past year.
In the past year CSPN has reported a negative cash flow from operations.
CSPN.CA Yearly Net Income VS EBIT VS OCF VS FCFCSPN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 -2M -4M -6M

1.2 Ratios

Industry RankSector Rank
ROA -221.37%
ROE N/A
ROIC N/A
ROA(3y)-450.25%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CSPN.CA Yearly ROA, ROE, ROICCSPN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 500 -500 1K 1.5K

1.3 Margins

CSPN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CSPN.CA Yearly Profit, Operating, Gross MarginsCSPN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 -20 -40 -60 -80 -100

More info and screens

0

2. Health

2.1 Basic Checks

CSPN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CSPN has been increased compared to 1 year ago.
Compared to 1 year ago, CSPN has a worse debt to assets ratio.
CSPN.CA Yearly Shares OutstandingCSPN.CA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 10M 20M 30M 40M
CSPN.CA Yearly Total Debt VS Total AssetsCSPN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 500K 1M 1.5M 2M 2.5M

2.2 Solvency

CSPN has an Altman-Z score of -94.30. This is a bad value and indicates that CSPN is not financially healthy and even has some risk of bankruptcy.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -94.3
ROIC/WACCN/A
WACC8.83%
CSPN.CA Yearly LT Debt VS Equity VS FCFCSPN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 -500K -1M -1.5M -2M -2.5M

2.3 Liquidity

CSPN has a Current Ratio of 0.12. This is a bad value and indicates that CSPN is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.12 indicates that CSPN may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.12
Quick Ratio 0.12
CSPN.CA Yearly Current Assets VS Current LiabilitesCSPN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 1M 2M 3M

More info and screens

0

3. Growth

3.1 Past

CSPN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 53.71%, which is quite impressive.
The Revenue for CSPN has decreased by -44.33% in the past year. This is quite bad
EPS 1Y (TTM)53.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60.61%
Revenue 1Y (TTM)-44.33%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-70.01%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CSPN.CA Yearly Revenue VS EstimatesCSPN.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 1M 2M 3M 4M 5M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CSPN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CSPN.CA Price Earnings VS Forward Price EarningsCSPN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CSPN.CA Per share dataCSPN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 -0.04 -0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CSPN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CARESPAN HEALTH INC

TSX-V:CSPN (2/7/2025, 7:00:00 PM)

0.02

+0.01 (+33.33%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners31.85%
Ins Owner ChangeN/A
Market Cap952.40K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.39
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.05
BVpS-0.08
TBVpS-0.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -221.37%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-450.25%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover5.08
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.12
Quick Ratio 0.12
Altman-Z -94.3
F-Score4
WACC8.83%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)53.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60.61%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-44.33%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-70.01%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y46.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y28.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y28.46%
OCF growth 3YN/A
OCF growth 5YN/A